American Journal of Physiology-Cell Physiology · 2022 · 26 citations · 35 references
MedicineMolecular GeneticsPathobiologyGene ExpressionRenal PathologyRenal PathophysiologyChronic Kidney DiseaseFibrosisMicrorna BiologyNoncoding Rna BiologyRenal DiseaseRenal FibrosisFibrogenic CytokinesLong Noncoding Rna InteractionsLuciferase Reporter AssaysMicrorna Regulation Of FibrogenesisProtein Expression LevelsRenal Fibrosis MechanismsRna ImmunoprecipitationWestern Blot Analysis
Renal fibrosis is the final pathway for chronic kidney disease to end-stage renal failure. Noncoding RNAs have been reported to play a crucial role in renal fibrosis. Here, the effects of long noncoding RNA (lncRNA) nuclear-enriched abundant transcript 1 (NEAT1) and miR-31 on renal fibrosis and their regulatory mechanism were evaluated. RT-qPCR was used to assess NEAT1, miR-31, and RhoA levels. Western blot was performed to analyze the expression of fibrosis markers, RhoA, rho-related kinase (ROCK1), and connective tissue growth factor (CTGF). RNA immunoprecipitation (RIP), fluorescence in situ hybridization (FISH), and luciferase reporter assays verified the interaction between miR-31 and NEAT1 or RhoA. Renal fibrosis and injury were observed by Masson and hematoxylin and eosin (H&E) staining. The expression level of inflammatory cytokines was detected by ELISA. Immunohistochemistry (IHC) was performed to examine the expression levels of α-smooth muscle actin (α-SMA) and RhoA in renal tissues. We showed that NEAT1 was highly expressed, whereas miR-31 was decreased in renal fibrosis. NEAT1 was found to directly bind miR-31 to positively regulate RhoA expression. Furthermore, NEAT1 silencing inhibited renal fibrosis and inflammation and suppressed the RhoA/ROCK1 signaling pathway. However, knockdown of miR-31 could reverse these effects. NEAT1 silencing or overexpression of miR-31 alleviated renal fibrosis in vivo. In conclusion, NEAT1 accelerates renal fibrosis progression via negative regulation of miR-31 and the activation of RhoA/ROCK1 pathway, thereby upregulating the expression level of CTGF, providing a theoretical basis for treatment and prognostic evaluation of renal fibrosis.
35
Michael Zeisberg, Gary D. Bonner, Yohei Maeshima et al. · American Journal Of Pathology · 2001 · 295 citations · Full text
Deficient Autophagy Results in Mitochondrial Dysfunction and FSGS
Takahisa Kawakami, Ivan G. Gomez, Shuyu Ren et al. · Journal of the American Society of Nephrology · 2014 · 174 citations · Full text
Medicine, Pathobiology, Pathology +17